Nephrocare Health Services Limited

₹605.95As of Sun 8 Nov 2026, 12:00 UTC
NSE:NEPHROPLUSHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Medical Care Facilities
Beta (5Y) —
PE TTM 47.75
TSR TTM —
Mkt cap ₹60.93B
ROIC 15.75%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹699
15.42%
(86.35%)
Hold 7|12|9|10|10
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
11.53
11.77
12.03
12.48
31.34%
21.90%
11.44%
4.93%
Revenue₹B
3.102
3.207
3.231
3.382
18.66%
15.85%
15.01%
13.75%
Peers (US$648.9M)
Cap (US$)
PE
845.7M
60.58x
516.8M
42.31x
Capital
TTM
5Y
10Y
Leveragex
2.210
0.125
0.102
EBIT/Intx
2.497
0.076
0.087
Own earn%
189.01
(74.72)
(62.25)
Sh yield%
54.75
41.63
41.84
Owners
Insiders/Inst%
12.20
37.49
Short interest%
5.20
SBC / revenue%
1.76
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
14–24
$1 testx
—
Incr. ROIC%
1